Back to Search
Start Over
60 Degrees Pharmaceuticals to sponsor pilot study of tafenoquine
- Source :
- The Fly. April 3, 2024
- Publication Year :
- 2024
-
Abstract
- 60 Degrees Pharmaceuticals announced that the Company will sponsor a pilot study of tafenoquine, the active molecule in its U.S. Food and Drug Administration-approved human malaria prevention medication, ARAKODA, for [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.788589732